Skip to main content

Table 1 Demographic and clinical variables in the study subjects

From: Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life

VariableMean (±SD)MinimumMaximum
Age (years)36.35 ± 7.3322.0050.00
Duration of marriage (years)15.07 ± 8.550.1633.00
Disease duration (years)7.37 ± 5.400.0226
Age at diagnosis (years)27.92 ± 7.5711.0049.50
EDSS2.06 ± 1.850.007.50
Fatigue3.65 ± 1.571.007.00
Anxiety13.18(9.18)020
Depression13.46(9.57)028
Stress19.59(10.03)034
QOLPhysical health composite score62.66 ± 19.1515.4296.24
Mental health composite score60.75 ± 19.999.0797.34
Education
N (%)
Secondary school or below74 (24.7)
High school132 (44.0)
University94 (31.3)
Occupation
N (%)
Housewife258 (86.0)
Employed33 (11.0)
Retired9 (3.0)
Disease pattern
N (%)
Relapsing-Remitting MS (RRMS)243 (81.0)
Progressive MS39 (13.0)
Clinically Isolated Syndrome (CIS)18 (6.0)
Taking medications
N (%)
No30 (10.0)
Yes
270 (90.0)
Disease Modifying Therapy (DMT)141 (47.0)
Anticholinergic drugs51 (17.0)
Psychiatric drugs8 (2.7)
Antidepressants drugs56(18.7)
Benzodiazepines drugs18(6.0)
Anticonvulsants drugs50(16.7)
  Beta blockers drugs17 (5.7)
Antispasmodic drugs (baclofen,tizanidine, Methocarbamol)38(12.7)
Complementary drugs183 (61.0)